As of January 8, 2010 a total of 20 deaths have been reported, of which two are new reports since the previous summary published on December 11. Some of the previously reported cases are still under investigation. In this summary only the new cases are commented.AND
One of the new cases involves a man (40 years of age) which died in his sleep 4 days after vaccination. From what has emerged so far, there is no information that confirms a causal association between the vaccination and the death, but an autopsy is requested for further assessment of the possible cause of death.
The other case concerns a 22 year old female with Retts syndrome, colitis ulcerosa, epilepsy and a recently diagnosed collum fracture who seeked healthcare due to cough, fever and convulsions. The patient was treated with antibiotics, improved temporarily but subsequently deteriorated, and became anoxic and tachypnoic due to interstitial pneumonitis. The patient died and the rapporteur could not exclude an association with Pandemrix which was given 2 days before hospitalisation.
Since the vaccination campaign with Pandemrix began in Sweden on October 12, more than 2000 consumer reports of suspected adverse reactions have been received by the Medical Products Agency. About 260 reports have been received since the last published summary in December. About 25 of these 260 reports include adverse events that have been classified as serious.Yes, "considerable inconveniences" considering it was a pandemic scam and that it was less morbid then an average seasonal flu.
Among the 33 serious events recently reported by consumers there are 6 cases of miscarriages at an early stage of the pregnancy and one case of intrauterine foetal death. Two cases of thrombocytopenia in children which have been diagnosed and treated in a pediatric clinic and moreover two cases of facial palsy and three cases of visual disturbances have also been reported. One case with Guillain-Barré syndrome has been reported both via the consumer reporting system and from health care professionals.
The reported non-serious reactions are as previously, mainly flu-like symptoms, significant and/or long lasting pains at the injection site (the arm). Despite that the majority of the reports do not include serious reactions it is clear from the descriptions that in many cases it has caused considerable inconveniences.
Link to the full report


0 commentaires:
Enregistrer un commentaire